Blood of the Unborn

A high-ranking FSB officer has long been overseeing an important effort to produce a very unusual medicine that restores strength and health, extends youth, and prolongs vitality. Demand creates supply: production of the drug needs to be increased. And money is available—big money—there are proven technologies, and there are interested parties. The only thing missing is raw material—unusual raw material: embryos of 25-week-old unborn infants.